GLP-1: More Than a Metabolic Hormone Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly becoming one...
GLP-1s Blogs
Great strategies start with understanding People. Explore our GLP-1s blogs for insights on HCP and Patient intelligence, workforce engagement, data science, and the latest industry news.
The GLP-1 Narrative is Splitting: Convenience vs Coverage
The GLP-1 Inflection Point Coming out of industry news this past week are two developments that, on the surface, look...
Talking Medicines and Socialgist Partner to Capture the GLP-1 Consumer Voice from Real-Life Conversations
The GLP-1 consumer shift is clear, but the signals behind it are often hard to see. That’s why we’ve partnered with...
GLP-1s and the Information Explosion: When Consumer Curiosity Meets AI-Driven Health Decisions
The Rise of the Health-Seeking Consumer We are witnessing a fundamental shift: Patients are no longer simply passive...
GLP-1s in India: A New Frontier in Affordable Weight Loss and Diabetes Care
The Patent Cliff That Changed Everything Within days of the patent expiry, Indian pharmaceutical companies launched a...
The Expanding Horizon of GLP-1 Therapies: Beyond Diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists have long been established as effective treatments for type 2...
Why the GLP-1 Story Keeps Changing and Why Strategy Leaders Should Pay Attention
GLP-1 receptor agonists (GLP-1s) are evolving quickly, not just in terms of clinical evidence, but in how Healthcare...
GLP-1 Receptor Agonists and the Future of Metabolic Health
GLP-1RAs: Rapid Disruption, Regulatory Shifts & The Rise of Intelligent Health Information In less than a...
Elevating Healthcare Strategy: Unmasking Game-Changing Insights on GLP-1 & GIP/GLP-1 with Drug-GPT Technology
In collaboration with our partners at Sermo, our Advanced Data Science and Artificial Intelligence solutions played a...
GLP-1 Drugs and AI: Revolutionizing Healthcare Marketing through Unstructured Data
In the healthcare sector, the continuous evolution of drug development and Patient engagement demands ongoing...
GLP-1 Agonists: A New Era in Treating Obesity and Type 2 Diabetes
The World Health Organization (WHO) has sounded the alarm on the global obesity crisis, labelling it an "epidemic"...